ArticleJournal of cellular and molecular medicine2015

Intensified antineoplastic effect by combining an HDAC-inhibitor, an mTOR-inhibitor and low dosed interferon alpha in prostate cancer cells.

Igor Tsaur et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.